Net margin · Fiscal year 2025
| 1 | United TherapeuticsUTHR | 41.9% |
|---|---|---|
| 2 | PTC TherapeuticsPTCT | 39.5% |
| 3 | NovavaxNVAX | 39.2% |
| 4 | Acadia PharmaceuticalsACAD | 36.5% |
| 5 | ExelixisEXEL | 33.7% |
| 6 | Novo Nordisk A SNVO | 33.1% |
| 7 | Vertex PharmaceuticalsVRTX | 32.9% |
| 8 | Royalty PharmaRPRX | 32.4% |
| 9 | Eli LillyLLY | 31.7% |
| 10 | Regeneron PharmaceuticalsREGN | 31.4% |